Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Densiron (specifically Densiron 68) is a high-density silicone oil used as an intraocular tamponade agent in vitreoretinal surgery. It is a homogeneous mixture of perfluorohexyloctane (F6H8), a semifluorinated alkane, and high-viscosity silicone oil (polydimethylsiloxane). With a density of approximately 1.06 g/cm³, it is heavier than water, allowing it to sink and exert downward tamponade pressure on the inferior retina. This property makes it specifically indicated for the treatment of complex inferior rhegmatogenous retinal detachments, particularly those complicated by proliferative vitreoretinopathy (PVR). Developed by Fluoron GmbH, it is typically used as a temporary internal tamponade and is surgically removed after the retina has stabilized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Densiron.